A UNC Lineberger study published in the journal Breast Cancer Research and Treatment drew upon surveys that assessed health-related quality of life issues for women aged 20 to 74 years who lived in North Carolina and had breast cancer. The analysis was part of the third phase of the Carolina Breast Cancer Study.
Breast Cancer, Research, Treatment
The advent of targeted drugs for a specific type of breast cancer – HER2 positive – has dramatically improved survival rates for women with the disease. But a study led by researchers at the University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center reveals low rates of use o
Breast Cancer, Social Justice, Treatment, Women's Health
A UNC Lineberger-led study has identified genetic differences in tumors of African-Americans with the most common type of kidney cancer compared with whites. The researchers say the findings could help explain lower survival rates for African-Americans with clear cell renal cell carcinoma.
Cancer, Genetics, Social Justice
In a study published in the journal Annals of Surgery, researchers report that breast cancer patients surveyed about their knowledge of breast reconstruction were only moderately informed about the procedure, and their knowledge of complications was low.
Breast Cancer, Research, Treatment
With only one physician in Malawi trained to perform the surgical procedure required to treat cervical cancer—radical hysterectomy—women died in large numbers from the disease. Two UNC OB-GYNs came up with a way to change that.
Cancer, Collaboration
Ten-year-old Ellie Stewart was diagnosed with choriocarcinoma in February. Her only plans for the summer were to finish her chemotherapy treatment at N.C. Children’s Hospital. Then she received a surprise gift: tickets to attend Taylor Swift’s June 9 concert in Raleigh. Now Ellie has some...
Cancer, Patient Stories
Two new faculty members have joined the UNC Lineberger Comprehensive Cancer Center to help launch groundbreaking immunotherapy clinical trials that will test an experimental treatment in which patients’ own immune cells are genetically engineered to fight their cancer.
Cancer, Clinical Trials, Genetics
The latest installment in our Real Medicine video series features one of our Patient Ambassadors for North Carolina Children's Hospital.
Cancer, Patient Stories
Device that drives drugs into solid tumors that are poorly vascularized opens the possibility of life-saving surgeries in cancer patients. James Byrne, PhD, a medical student and member of Joseph DeSimone’s lab, led the research by constructing the device and examining its ability to deliver chemotherapeutic drugs effectively to pancreatic cancer tumors, as well as two types of breast cancer tumors.
Cancer, Research, Treatment
Carolina legend Danny Talbott performed at the highest level on both the football field and baseball diamond during his years as a Tar Heel. Since 2010, he’s been back in Chapel Hill, battling the toughest opponent he’s faced: multiple myeloma. He can’t imagine going anywhere else to do it.
Cancer, Patient Stories
Breast Cancer, Cancer
Researchers from the UNC/NCSU Joint Department of Biomedical Engineering developed nanoparticles that could deliver cancer therapies in a safer and more effective way.
Cancer, Innovation, Treatment
